Defining the “Absence” of the CBFβ/MYH11 Fusion Transcript in Patients With Acute Myeloid Leukemia and Inversion of Chromosome 16 to Predict Long-Term Complete Remission: A Call for Definitions
Open Access
- 15 December 1997
- journal article
- Published by American Society of Hematology in Blood
- Vol. 90 (12), 5022-5024
- https://doi.org/10.1182/blood.v90.12.5022b
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Detection and quantitation of the CBFβ/MYH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AMLLeukemia, 1997
- A novel method for real time quantitative RT-PCR.Genome Research, 1996
- Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemiaBlood, 1996
- Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remissionBritish Journal of Haematology, 1995
- Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia [see comments]Blood, 1995
- Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemiasBlood, 1995
- Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplificationBlood, 1994
- Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemiaBlood, 1994